A vaccine against pneumococcal infections in children should be made available for free on the national health service, according to the advisory board on immunisation.

The three-dose vaccine is already available in the private sector but comes with a price tag of around €50 per dose.

Pneumococcal infection is a common cause of pneumonia, meningitis and blood infections and can even cause middle ear infections.

Immunisation Services coordinator Victoria Farrugia Santangelo, who is also the secretary of the immunisation board, said they were also looking at the possibility of recommending the introduction of vaccines against the potentially cancer-causing human papilloma virus and another against rotavirus, the leading cause of severe diarrhoea among infants and young children.

Speaking at a press conference to mark the fourth European Immunisation Week, which kicked off on Monday, health authorities spoke about the importance of making good use of vaccines.

Dr Farrugia Santangelo said Malta already had a very good take-up of immunisation, although the available statistics did not cover all the vaccines given in the private sector. She encouraged general practitioners to report all vaccinations they gave.

This year the accent was being placed on the fact that immunisation saved the lives of more than three million people worldwide every year, but infectious diseases were still the leading causes of child death. The World Health Organisation stressed that immunisation was one of the most cost-effective health achievements of modern times.

"Parents no longer see children crippled by polio because it has been eradicated from Europe but we still have other vaccine-preventable diseases around us, including measles, mumps, rubella, Hepatitis B, meningitis, pneumococcal pneumonia, influenza and chicken pox," the health authorities said in a press release.

Dr Farrugia Santangelo said the aim was to eradicate measles by next year, although this was not a problem for Malta, which had not seen a case for the past two years.

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.